Delivery Order SPE2DB24D3014-SPE2DB25FKUTV
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 17, 2025, by the Defense Logistics Agency for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens, with a ceiling value of $3,126.29. This is a firm fixed price, non-set-aside contract with a completion date of July 18, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,143.19 by the Defense Logistics Agency on September 11, 2025, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 12, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The delivery order, valued at $5,458.35, is for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. The contract has a completion date of August 5, 2024 and is a firm fixed-price delivery order. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and...
- The Defense Logistics Agency awarded a $1,211.75 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens. This firm fixed price, non-competitive delivery order was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. The order was fulfilled at the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with a ceiling value of $1,582.33 and a firm fixed price structure. The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Tresiba FlexTouch 100 unit/mL insulin pens in 3mL quantities. This $2,146.80 firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract for $2,001.55 to supply Tresiba Flextouch 200 unit/mL 3mL insulin pens. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- The Defense Logistics Agency awarded a delivery order valued at approximately $74,717 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes a firm fixed price structure and carries no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $2,491.38 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 200 Unit/ML insulin pens (3 ML). This competitively awarded, firm fixed-price delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,640.04 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by July 30, 2025. The contract will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKUTVDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) for Tresiba FlexTouch 200 Unit/mL 3mL insulin pens, with a ceiling value of $2,491.38. The award, issued on September 22, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025. This is a competitively awarded contract with no set-aside designation. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 global pharmaceutical supply vehicle valued through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through its extensive contract portfolio with DLA and the Defense Health Agency. The company's federal procurement activity demonstrates significant capability in supplying brand-name medications, generic pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains. As a major healthcare solutions provider in the federal supply chain, AmerisourceBergen fulfills medical commodity needs ranging from small-value transactions to substantial orders, supporting military healthcare programs worldwide through its comprehensive prime vendor arrangement with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/22/25 |